AcelRx Pharmaceuticals, Inc. (ACRX): Price and Financial Metrics

ACRX POWR Grades

• Value is the dimension where ACRX ranks best; there it ranks ahead of 68.31% of US stocks.
• ACRX's strongest trending metric is Quality; it's been moving down over the last 32 days.
• ACRX ranks lowest in Stability; there it ranks in the 5th percentile.

ACRX Stock Summary

• ACRX's current price/earnings ratio is 0.38, which is higher than merely 0.04% of US stocks with positive earnings.
• ACRX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 1.35% of US stocks.
• In terms of volatility of its share price, ACRX is more volatile than 99.78% of stocks we're observing.
• Stocks with similar financial metrics, market capitalization, and price volatility to ACELRX PHARMACEUTICALS INC are KALA, LVO, AMRS, MDXG, and OPTN.
• Visit ACRX's SEC page to see the company's official filings. To visit the company's web site, go to www.acelrx.com.

ACRX Valuation Summary

• ACRX's price/sales ratio is 11.5; this is 475% higher than that of the median Healthcare stock.
• ACRX's EV/EBIT ratio has moved up 7.4 over the prior 144 months.

Below are key valuation metrics over time for ACRX.

ACRX Growth Metrics

The 4 year net income to common stockholders growth rate now stands at -28.58%.
• The 2 year net cashflow from operations growth rate now stands at 44.12%.
• Its year over year net income to common stockholders growth rate is now at -4.21%.

ACRX's revenue has moved down $1,539,000 over the prior 15 months.

The table below shows ACRX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	1.521	-30.922	47.136
2022-06-30	2.876	-29.627	45.697
2022-03-31	2.749	-29.228	-34.817
2021-12-31	2.818	-30.002	-35.099
2021-09-30	3.554	-28.325	-36.1
2021-06-30	3.06	-32.506	-36.655

ACRX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ACRX has a Quality Grade of F, ranking ahead of 2.01% of graded US stocks.
• ACRX's asset turnover comes in at 0.041 -- ranking 335th of 680 Pharmaceutical Products stocks.
• JNJ, ORGS, and ABBV are the stocks whose asset turnover ratios are most correlated with ACRX.

The table below shows ACRX's key quality metrics over time.